Assembly BillIntroduced
A 7112: Authorizes and directs the department of health to conduct a study on drugs prescribed for school-age children with ADD and ADHD.
What A 7112 does, verified January 10, 2026
The bill aims to conduct a study on the effects of certain medications prescribed for attention deficit disorders and ADHD in school-age children. The study will focus on the harmful side effects of these medications, the effectiveness of diagnostic tools, and demographic disparities in diagnosis. The study will be conducted by the commissioner of health in conjunction with other relevant commissioners, and the findings will be reported to the governor, the speaker of the assembly, and the temporary president of the senate within two years of the bill's enactment.
Bill journey
1IntroducedCurrent
2In CommitteePending
3First Chamber FloorPending
4Second ChamberPending
5GovernorPending
6ChapteredPending
Last action: referred to health (2026-01-07)Alert me
Quick answers about A 7112
- What is the current status of A 7112?
- As of January 10, 2026, A 7112 is recorded as "Introduced": it has been introduced and is waiting for its first committee hearing or floor vote. The last recorded action, on January 7, 2026, was "referred to health".
- Did A 7112 pass?
- Not yet. A 7112 has been introduced and has not passed either house.
- Who wrote A 7112, and where is it now?
- A 7112 was authored by Asm. Latrice Walker with 4 coauthors. Its committee of record is Assembly Health.
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlockRecent actions2 total · showing 2
| Jan. 07, 2026 | referred to health |
| Mar. 20, 2025 | referred to health |
Latest bill textIntroduced version, March 20, 2025 · 321 words
STATE OF NEW YORK ________________________________________________________________________ 7112 2025-2026 Regular Sessions IN ASSEMBLY March 20, 2025 ___________ Introduced by M. of A. WALKER, STECK, SANTABARBARA, COOK, BENDETT -- read once and referred to the Committee on Health AN ACT authorizing and directing the department of health to do research and study as to the effects of psychostimulants, selective seratonin reuptake inhibitors, antidepressants and other drugs which are prescribed for attention deficit disorders, ADD and ADHD, for school age children The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. 1. The commissioner of health, in conjunction with the 2 commissioner of mental health, the commissioner of developmental disa- 3 bilities, and the commissioner of education is authorized and directed 4 to conduct a study and do research as to the effect of psychostimulants, 5 selective serotonin reuptake inhibitors, antidepressants and other drugs 6 prescribed for attention deficit disorder, attention deficit hyperactiv- 7 ity disorder, and the increasing rate of diagnosis of these conditions, 8 in school age children. 9 2. The study shall be conducted in accordance with rules, regulations 10 and standards determined by the commissioner of health, and the study 11 shall concentrate on harmful side effects of such drugs, the appropri- 12 ateness and effectiveness of tools and methods used to assess and diag- 13 nose the condition, the appropriateness of different medications, and 14 any demographic disparities in diagnosis. 15 3. The commissioner of health shall report the findings of the study 16 to the governor, the speaker of the assembly and the temporary president 17 of the senate on or before two years from the date this act shall take 18 effect. 19 § 2. This act shall take effect immediately. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD06855-01-5
Text of A 7112 as introduced, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions